Skip to content

Clinical trials

Completed Schizophrenia trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Switzerland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20071
20082
20101
20111
20163
20182
20192
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Bern5
AstraZeneca2
Janssen-Cilag International NV2
Psychiatric University Hospital, Zurich2
Institut et Haute Ecole de la Santé la Source1
Janssen Pharmaceutica N.V., Belgium1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Rene Kahn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia16
Psychotic Disorders7
Major Depressive Disorder2
Psychomotor Disorders2
Anhedonia1
Bipolar Disorder1
Hallucinations1
Lethargy1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.